Current and historical daily PS Ratio for TFX (
Teleflex Inc
) from 1990 to Jul 21 2026. The price to sales ratio is calculated by taking the current stock price and dividing it by the trailing twelve-month sales per share. The data is updated every 20 minutes during market hours. The PS ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS ratio is a great valuation tool for evaluating cyclical businesses where the PE ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean. Teleflex stock (TFX) PS ratio as of Jul 21 2026 is 3.24.
More Details
Teleflex Inc (TFX) PS Ratio Chart
Teleflex Inc (TFX) PS Ratio Historical Data
View and export this data going back to 1990. Start your Free Trial
Total 1207
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Teleflex PS Ratio Historical Data | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date | PS Ratio Data | Date | PS Ratio Data | ||||||
| 2026-07-21 | 3.2 | 3.25 | 3.18 | 3.23 | 2026-05-14 | 3.1 | 3.18 | 3.11 | 3.13 |
| 2026-07-20 | 3.2 | 3.25 | 3.17 | 3.22 | 2026-05-13 | 3.1 | 3.17 | 3.06 | 3.12 |
| 2026-07-17 | 3.3 | 3.34 | 3.22 | 3.23 | 2026-05-12 | 3.1 | 3.14 | 3.06 | 3.1 |
| 2026-07-16 | 3.2 | 3.34 | 3.19 | 3.25 | 2026-05-11 | 3.2 | 3.22 | 3.1 | 3.11 |
| 2026-07-15 | 3.1 | 3.24 | 3.12 | 3.16 | 2026-05-08 | 3.2 | 3.26 | 3.14 | 3.19 |
| 2026-07-14 | 3.2 | 3.24 | 3.07 | 3.13 | 2026-05-07 | 3.1 | 3.27 | 3.05 | 3.16 |
| 2026-07-13 | 3.3 | 3.3 | 3.25 | 3.27 | 2026-05-06 | 2.9 | 2.97 | 2.88 | 2.96 |
| 2026-07-10 | 3.3 | 3.29 | 3.22 | 3.26 | 2026-05-05 | 2.9 | 2.91 | 2.85 | 2.9 |
| 2026-07-09 | 3.2 | 3.27 | 3.12 | 3.22 | 2026-05-04 | 2.9 | 2.94 | 2.86 | 2.88 |
| 2026-07-08 | 3.2 | 3.18 | 3.11 | 3.13 | 2026-05-01 | 3.0 | 2.97 | 2.89 | 2.92 |
| 2026-07-07 | 3.3 | 3.28 | 3.2 | 3.21 | 2026-04-30 | 3.2 | 3.19 | 2.96 | 2.98 |
| 2026-07-06 | 3.2 | 3.25 | 3.18 | 3.22 | 2026-04-29 | 3.2 | 3.28 | 3.19 | 3.2 |
| 2026-07-02 | 3.2 | 3.23 | 3.08 | 3.22 | 2026-04-28 | 3.2 | 3.26 | 3.2 | 3.25 |
| 2026-07-01 | 3.1 | 3.14 | 3.07 | 3.12 | 2026-04-27 | 3.3 | 3.31 | 3.23 | 3.24 |
| 2026-06-30 | 3.0 | 3.06 | 3 | 3.04 | 2026-04-24 | 3.3 | 3.32 | 3.22 | 3.28 |
| 2026-06-29 | 3.1 | 3.1 | 3.04 | 3.06 | 2026-04-23 | 3.3 | 3.33 | 3.24 | 3.28 |
| 2026-06-26 | 3.0 | 3.16 | 3.04 | 3.12 | 2026-04-22 | 3.3 | 3.35 | 3.21 | 3.33 |
| 2026-06-25 | 3.0 | 3.12 | 3.02 | 3.07 | 2026-04-21 | 3.2 | 3.17 | 2.99 | 3 |
| 2026-06-24 | 3.0 | 3.06 | 3 | 3.04 | 2026-04-20 | 3.1 | 3.21 | 3.1 | 3.17 |
| 2026-06-23 | 2.9 | 2.99 | 2.91 | 2.98 | 2026-04-17 | 3.2 | 3.24 | 3.09 | 3.16 |
| 2026-06-22 | 3.0 | 3.04 | 2.9 | 2.92 | 2026-04-16 | 3.0 | 3.14 | 2.96 | 3.13 |
| 2026-06-18 | 3.0 | 3.06 | 2.98 | 3.05 | 2026-04-15 | 3.0 | 3.04 | 2.98 | 3.03 |
| 2026-06-17 | 3.0 | 3.1 | 2.98 | 3 | 2026-04-14 | 3.0 | 3.03 | 2.95 | 3.01 |
| 2026-06-16 | 3.1 | 3.12 | 3.04 | 3.07 | 2026-04-13 | 2.9 | 2.96 | 2.85 | 2.96 |
| 2026-06-15 | 3.1 | 3.18 | 3.09 | 3.12 | 2026-04-10 | 2.9 | 2.91 | 2.83 | 2.84 |
| 2026-06-12 | 3.1 | 3.18 | 3.06 | 3.13 | 2026-04-09 | 2.9 | 2.91 | 2.84 | 2.89 |
| 2026-06-11 | 3.2 | 3.18 | 3.1 | 3.1 | 2026-04-08 | 2.8 | 2.87 | 2.82 | 2.86 |
| 2026-06-10 | 3.2 | 3.28 | 3.17 | 3.17 | 2026-04-07 | 2.8 | 2.8 | 2.74 | 2.77 |
| 2026-06-09 | 3.2 | 3.27 | 3.17 | 3.26 | 2026-04-06 | 2.8 | 2.84 | 2.75 | 2.76 |
| 2026-06-08 | 3.2 | 3.2 | 3.16 | 3.16 | 2026-04-02 | 2.8 | 2.86 | 2.76 | 2.83 |
| 2026-06-05 | 3.2 | 3.21 | 3.1 | 3.12 | 2026-04-01 | 2.9 | 2.89 | 2.84 | 2.84 |
| 2026-06-04 | 3.1 | 3.18 | 3.12 | 3.17 | 2026-03-31 | 2.8 | 2.88 | 2.78 | 2.87 |
| 2026-06-03 | 3.0 | 3.11 | 3.02 | 3.09 | 2026-03-30 | 2.8 | 2.8 | 2.73 | 2.76 |
| 2026-06-02 | 3.0 | 3.09 | 2.99 | 3.01 | 2026-03-27 | 3.0 | 3.06 | 2.96 | 3.04 |
| 2026-06-01 | 3.1 | 3.1 | 3 | 3.06 | 2026-03-26 | 2.8 | 2.9 | 2.81 | 2.89 |
| 2026-05-29 | 3.1 | 3.12 | 3.07 | 3.09 | 2026-03-25 | 2.8 | 2.87 | 2.77 | 2.83 |
| 2026-05-28 | 3.1 | 3.12 | 3.06 | 3.11 | 2026-03-24 | 2.7 | 2.82 | 2.69 | 2.78 |
| 2026-05-27 | 3.2 | 3.2 | 3.1 | 3.12 | 2026-03-23 | 2.8 | 2.83 | 2.76 | 2.77 |
| 2026-05-26 | 3.2 | 3.21 | 3.15 | 3.17 | 2026-03-20 | 2.8 | 2.81 | 2.75 | 2.75 |
| 2026-05-22 | 3.2 | 3.24 | 3.16 | 3.19 | 2026-03-19 | 2.8 | 2.84 | 2.78 | 2.8 |
| 2026-05-21 | 3.2 | 3.25 | 3.16 | 3.17 | 2026-03-18 | 2.8 | 2.88 | 2.77 | 2.82 |
| 2026-05-20 | 3.2 | 3.26 | 3.17 | 3.25 | 2026-03-17 | 2.9 | 2.92 | 2.84 | 2.85 |
| 2026-05-19 | 3.1 | 3.23 | 3.11 | 3.19 | 2026-03-16 | 2.8 | 2.87 | 2.82 | 2.85 |
| 2026-05-18 | 3.1 | 3.24 | 3.12 | 3.13 | 2026-03-13 | 2.9 | 2.86 | 2.8 | 2.8 |
| 2026-05-15 | 3.1 | 3.14 | 3.09 | 3.11 | 2026-03-12 | 2.9 | 2.91 | 2.81 | 2.83 |
Teleflex Inc (TFX) PS Ratio Comparison
| Company | Market Cap(Mil) | PS Ratio |
|---|
Business Description
Business Description
Teleflex Inc
NAICS : 339112
SIC : 3841
ISIN : US8793691069
Total Employee Number:
15,500Description
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers